The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2020
Filed:
Oct. 29, 2018
Applicant:
Sanofi Pasteur Inc., Swiftwater, PA (US);
Inventor:
Robert P. Ryall, Stroudsburg, PA (US);
Assignee:
Sanofi Pasteur Inc., Swiftwater, PA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/095 (2006.01); A61K 47/64 (2017.01); A61K 39/116 (2006.01); A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 47/61 (2017.01); A61K 47/24 (2006.01); A61K 47/02 (2006.01); A61K 47/08 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 39/095 (2013.01); A61K 39/116 (2013.01); A61K 39/39 (2013.01); A61K 47/02 (2013.01); A61K 47/08 (2013.01); A61K 47/24 (2013.01); A61K 47/61 (2017.08); A61K 47/646 (2017.08); A61K 47/6415 (2017.08); A61K 2039/55505 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/70 (2013.01);
Abstract
The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteriaThe vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purified capsular polysaccharides fromserogroups A, C, W-135, and Y are chemically activated and selectively attached to a carrier protein by means of a covalent chemical bond, forming polysaccharide-protein conjugates capable of eliciting long-lasting immunity to a variety ofstrains in children as well as adults.